We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

FDA Explains Expectations For Drugmakers' Data Retention

Law360 (December 12, 2018, 11:02 PM EST) -- The U.S. Food and Drug Administration answered drugmakers’ questions Wednesday about how to maintain data from drug tests and the manufacturing floor, following an uptick in violations of federal information retention...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.